Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Autolus Therapeutics Reports Net Loss Per Share Of $(1.20) In FY23 Compared With $(1.57) YoY, Company Exits FY23 With Cash And Equivalents Worth $239,57M

Author: Benzinga Newsdesk | March 14, 2024 07:07am

Posted In: AUTL